Curb Your Enthusiasm For Continued Use Of Pandemic Clinical Trial Flexibilities, US FDA Says

Hold your horses
The FDA is asking firms to hold their horses on permanently adopting all COVID-19 pandemic flexibilities, saying more research of their effectiveness is necessary. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Clinical Trials

More from R&D